Anti-cyclic citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) relation with extra-articular manifestations in rheumatoid arthritis.

MLA

Gonzalez-Lopez, Laura, et al. “Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vimentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis.” Journal of Immunology Research, vol. 2014, 2014, p. 536050. EBSCOhost, https://doi.org/10.1155/2014/536050.

APA

Gonzalez-Lopez, L., Rocha-Muñoz, A. D., Ponce-Guarneros, M., Flores-Chavez, A., Salazar-Paramo, M., Nava, A., Cardona-Muñoz, E. G., Fajardo-Robledo, N. S., Zavaleta-Muñiz, S. A., Garcia-Cobian, T., & Gamez-Nava, J. I. (2014). Anti-cyclic citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) relation with extra-articular manifestations in rheumatoid arthritis. Journal of Immunology Research, 2014, 536050. https://doi.org/10.1155/2014/536050

Chicago

Gonzalez-Lopez, Laura, Alberto Daniel Rocha-Muñoz, Manuel Ponce-Guarneros, Alejandra Flores-Chavez, Mario Salazar-Paramo, Arnulfo Nava, Ernesto German Cardona-Muñoz, et al. 2014. “Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vimentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis.” Journal of Immunology Research 2014: 536050. doi:10.1155/2014/536050.